Rising Antimicrobial Resistance Poses Critical Threat to Neurocritical Care Patients ~ Leading Neurocritical Care Experts Convened at the highly successful 7th Annual National Conference of the Society of Neurocritical Care of India (SNCC) on September 21-22, 2024, Mumbai to address the pressing need for novel anti-infective treatments in
Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Limited, and includes its subsidiaries or associate companies) and Israel-based Moebius Medical Limited announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to MM-II (Large
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) today announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for MamitraTM, a Trastuzumab biosimilar. The drug will be marketed in different strengths
Dr Shivani Sharma, Vice-President of Pathology Services and Lab Director India is experiencing a significant change in healthcare towards personalized and precision medicine due to the advancements in molecular testing technologies. This change is leading to new possibilities in disease diagnosis, treatment selection, and patient care.
Dr. Pinaki Mahato, Consultant - Medical Oncology, HCG Cancer Centre, Vadodara In recent years, advancements in medical research have led to the development of targeted therapies for various cancers, offering new hope for patients. These therapies focus on specific molecules and pathways critical to cancer cell
Newcastle University’s scientists have identified genetic alterations that can result in children being born with minimal or no immune defense against infections. Newcastle University’s researchers identified mutations in the NUDCD3 gene that are associated with Severe Combined Immunodeficiency and Omenn syndrome, which are rare and life-threatening
Dr. Pinaki Mahato, Consultant - Medical Oncology, HCG Cancer Centre, Vadodara. In recent years, advancements in medical research have led to the development of targeted therapies for various cancers, offering new hope for patients. These therapies focus on specific molecules and pathways critical to cancer cell
Dr. Raghunath S.K, Senior Consultant and Director of Uro-oncology and Robotic Surgery HCG Cancer Centre, KR Road, Bangalore In the fight against kidney cacer, especially in its advanced stages, the advent of immunotherapy has brought new hope. Imagine your body's immune system as an army fighting invaders like germs.
Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,
Treatment of Kidney failure, liver failure and thalassemia is completely possible with Ayurveda. This was said by the doctors and patients of HIIMS in a press conference held on November 20th at HIIMS Navi Mumbai. Acharya Manish, the founder of HIIMS Ayurveda, who is always
